According to FutureWise analysis the market for Amphotericin B in 2023 is US$ 0.23 billion, and is expected to reach US$ 0.34 billion by 2031 at a CAGR of 4.80%.
Amphotericin B injection is used to treat severe and potentially life-threatening fungal infections. Amphotericin B injection is in the class of medications called antifungals. It works by delaying the growth of fungi that cause disease. Amphotericin B medicine approved by the U.S. Food and Drug Administration (FDA) for treating fungal infections, such as histoplasmosis and cryptococcosis. The FDA-approved uses for amphotericin B vary depending on the formulation of the drug. Many of the infections for which amphotericin B treatment is FDA-approved can be opportunistic infections (OIs) of HIV. An opportunistic infection is a disease that occurs more frequently and is more severe in people with weakened immune systems such as HIV, than in people with healthy immune systems.
Amphotericin B injection comes with a solid powder cake which will convert into a solution and then be injected intravenously (into the vein) by a nurse or doctor. Amphotericin B injection is usually administered by slow infusion intravenously for 2 to 6 hours once daily. Before receiving the first dose, the person may receive a test dose for 20 to 30 minutes to see if the person can tolerate the medication. The length of the treatment depends on general health, how the person handles the drug, and the type of infection. The person can also encounter a reaction after you receive the dose of amphotericin B injection. These reactions usually occur 1 to 3 hours after starting your infusion and are more severe with the first few doses. Your healthcare provider can prescribe different medications to decrease these side effects.
FutureWise Market Research has published a report that provides an insightful amphotericin B market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, amphotericin B market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.